Krista Davis - 19 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Krista Davis, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
19 Feb 2026
Net transactions value
-$296,495
Form type
4
Filing time
23 Feb 2026, 17:31:33 UTC
Previous filing
17 Feb 2026
Next filing
02 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Krista SVP, CHIEF HR OFFICER C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Krista Davis, by attorney-in-fact Meredith W. Cook 23 Feb 2026 0001946439

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $161,573 -2,084 -3.9% $77.53 50,993 19 Feb 2026 Direct F1
transaction ANIP Common Stock Sale $134,923 -1,730 -3.4% $77.99 49,263 20 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025.
F2 The shares were sold in multiple trades at prices ranging from $77.45 to $78.58. The price reported above reflects the weighted average sales price.